Investing Ideas
/
Egyptian Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Egyptian Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Egyptian International Pharmaceutical Industries

Market Cap: ج.م8.6b

Manufactures and sells pharmaceutical ampoules in Egypt and internationally.

PHAR

ج.م51.10

-1.1%

40.0%